Clinical risk factors associated with malignancy in TIF1-γ(+) dermatomyositis

被引：0
|
作者：
Cassard, L. [1 ,2 ]
Flatley, E. [2 ,4 ]
Fernandez, A. P. [2 ,3 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH USA
[2] Cleveland Clin, Dermatol, Cleveland, OH USA
[3] Cleveland Clin, Pathol, Cleveland, OH USA
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Newark, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
152
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] Variability in malignancy ratios in dermatomyositis patients with anti-TIF-1 antibodies via line immunoassay versus immunoprecipitation
    Westerdahl, Skylar
    Rhoads, Jamie L. W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB104 - AB104
  • [42] Dermatomyositis-erythrodermia: Clinical presentation not associated to malignancy. A case report
    Valdes-Gonzalez, Guillermo
    Chavez-Lopez, Mario
    Gallaga-Gutierrez, Adan
    Reyes-Garcia, Adriana
    REUMATOLOGIA CLINICA, 2014, 10 (01): : 48 - 50
  • [43] Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis
    Wolstencroft, Paige W.
    Chung, Lorinda
    Li, Shufeng
    Casciola-Rosen, Livia
    Fiorentino, David F.
    JAMA DERMATOLOGY, 2018, 154 (01) : 44 - 51
  • [44] Oral leukoplakia: risk factors associated with malignancy
    Coutinho, Jose Cunha
    Coutinho, Goncalo Cunha
    Mota, Beatriz
    Cruz, Leonor
    Caldas, Cecilia
    Palmela, Paulo
    Simao, Rita
    Nunes, Miguel
    Salvado, Francisco
    ORAL ONCOLOGY, 2021, 118
  • [45] Risk Factors Associated with Suicide in Esophageal Malignancy
    Bateson, B.
    Talukder, A.
    Jones, A.
    Lawson, A.
    Kruse, E.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S175 - S176
  • [46] Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker" A case report
    Karino, Kohei
    Fujieda, Yuichiro
    Kawamura, Takuya
    Abe, Nobuya
    Shimoyama, Shuhei
    Kono, Michihito
    Kato, Masaru
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    MEDICINE, 2018, 97 (49)
  • [47] Clinical Risk Factors for Malignancy in Pheochromocytomas and Paragangliomas
    Ayala-Ramirez, M.
    Hernandez, M.
    Habra, M. A.
    Busaidy, N. L.
    Cote, G.
    Rich, T. A.
    Waguespack, S.
    Jimenez, C.
    ENDOCRINE REVIEWS, 2010, 31 (03) : S840 - S840
  • [48] TIF1-γ抗体阳性皮肌炎合并食管癌1例并文献复习
    陈雯雯
    万志红
    张孟伟
    王婧
    赵清
    河南医学研究, 2025, 34 (02) : 381 - 384
  • [49] TIF1γ-overexpressing, Highly Progressive Endometrial Carcinoma in a Patient with Dermatomyositis Positive for Malignancy-associated Anti-p155/140 Autoantibody
    Kasuya, Akira
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Tokura, Yoshiki
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (06) : 715 - 716
  • [50] Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies
    Nhung Thi My Ly
    Ma, Ni
    Ueda-Hayakawa, Ikuko
    Chuyen Thi Hong Nguyen
    Anada, Reiko
    Okamoto, Hiroyuki
    Fujimoto, Manabu
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2021, 104 (03) : 177 - 184
12345